Delivery Order SPE2DB22D9304-SPE2DB24FSSX0

Award Date 6/21/24
Potential Completion Date 7/15/24
Potential Value $9.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $9,284.40, is for the delivery of Xolair 150 mg/mL syringes to support the medical supply needs of military healthcare facilities. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program. This IDC enables...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $9,284.40 and provides for the delivery of Xolair 150 mg/mL syringes to support the recurring medical supply needs of military healthcare facilities. The contract is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,568.80, is for the delivery of Xolair 150 mg/mL syringes to support the recurring medical supply needs of military health facilities. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,642.20, is for the delivery of Xolair 150 mg/mL syringes to support the medical supply needs of military healthcare facilities. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,284.40, is for the delivery of Xolair 150 mg/ml syringes to support the medical supply needs of military healthcare facilities. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the...
This is a firm fixed-price delivery order valued at $9,284.40 awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the supply of Xolair 150 mg/mL syringes, a specialized medication. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows the DLA to issue delivery orders for a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $37,137.60 contract is for the provision of Xolair 150 mg/mL syringes, a specialized medication, to support the recurring medical supply needs of military healthcare facilities. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
This firm fixed-price delivery order was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,094.80, is for the supply of Xolair 150 mg/ml syringes. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a wide...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,123.85 order is for the supply of Xolair 150 mg/mL syringes to support the recurring medical supply needs of military health facilities. The delivery order is part of a larger single-award indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at up to $6,189.60, is for the supply of Xolair 150 mg/mL syringes to support the recurring medical needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, which runs...
  • SPE2DB22D9304
    Indefinite Delivery Contract
  • SPE2DB22D9304-SPE2DB24FSSX0
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $9,284.40, is for the delivery of Xolair 150 mg/mL syringes to support the recurring medical supply needs of military health facilities worldwide.

The contract is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999 and running through December 31, 2025. This single-award IDC, under the DLA's SPE2DB program, allows the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to military healthcare facilities globally. The contract does not have a set-aside designation.

Generated 9/20/24, 9:32 AM